A PARTIAL BLOCKADE OF CATECHOLAMINERGIC NEUROTRANSMISSION WITH 6-HYDROXYDOPAMINE DECREASES MESSENGER-RNA LEVEL OF GONADOTROPIN-RELEASING-HORMONE IN THE MALE-RAT HYPOTHALAMUS

被引:21
作者
KIM, KJ
LIM, IS
CHO, BN
KANG, SS
LEE, BJ
CHOI, KH
CHUNG, CH
LEE, CC
CHO, WK
WUTTKE, W
机构
[1] SEOUL NATL UNIV, SRC CELL DIFFERENTIAT, SEOUL 151742, SOUTH KOREA
[2] ULSAN UNIV, DEPT BIOL, ULSAN, SOUTH KOREA
[3] CHUNG ANG UNIV, DEPT BIOL, SEOUL, SOUTH KOREA
[4] UNIV GOTTINGEN, DIV CLIN & EXPTL ENDOCRINOL, W-3400 GOTTINGEN, GERMANY
关键词
CATECHOLAMINES; HYPOTHALAMUS; GNRH GENE EXPRESSION; GNRH RELEASE; 6-HYDROXYDOPAMINE; NEUROTOXIN;
D O I
10.1159/000126524
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Central catecholamines (CA) are known to be involved in the regulation of synthesis and secretion of gonadotropin releasing hormone (GnRH) from the hypothalamus. However, no attempt has been yet made to determine whether CA affects GnRH gene expression. To this end, the effect of 6-hydroxydopamine (6-OHDA), a catecholaminergic neurotoxin, on GnRH mRNA level was examined. Hypothalamic tissues obtained from adult male rats were incubated with medium containing 6-OHDA. To ensure the effect of 6-OHDA on CA depleting action, CA levels in media and in postincubation tissues were determined. Increasing concentrations of 6-OHDA resulted in decrease in norepinephrine (NE) and dopamine (DA) contents in a dose dependent manner. Treatment with 6-OHDA (5 x 10(-4) M) produced a time-dependent decrease in NE but not DA, when CA levels in media were determined at 30 min intervals during the incubation period. To determine changes in GnRH mRNA level in response to 6-OHDA treatment in vitro, for 2.5 h total cytoplasmic RNA fractions were isolated from postincubation hypothalamic tissues and used for RNA-blot hybridization with 32P-labeled GnRH riboprobe. A blockade of CA neurotransmission with 6-OHDA (5 x 10(-4) M) Significantly reduced GnRH mRNA level by half over its control and internal control (actin mRNA) groups. Northern blot analysis revealed that addition of NE (1 X 10(-6) M) reversed the decreased GnRH mRNA level by 6-OHDA. These studies clearly demonstrated that GnRH mRNA level was modified by the combination of 6-OHDA and/or NE in rat hypothalamic tissues incubated in vitro, indicating that CA neurotransmission influences GnRH gene expression.
引用
收藏
页码:146 / 152
页数:7
相关论文
共 33 条
[1]   ISOLATION OF THE GENE AND HYPOTHALAMIC CDNA FOR THE COMMON PRECURSOR OF GONADOTROPIN-RELEASING-HORMONE AND PROLACTIN RELEASE-INHIBITING FACTOR IN HUMAN AND RAT [J].
ADELMAN, JP ;
MASON, AJ ;
HAYFLICK, JS ;
SEEBURG, PH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (01) :179-183
[2]   2 MAMMALIAN GENES TRANSCRIBED FROM OPPOSITE STRANDS OF THE SAME DNA LOCUS [J].
ADELMAN, JP ;
BOND, CT ;
DOUGLASS, J ;
HERBERT, E .
SCIENCE, 1987, 235 (4795) :1514-1517
[3]  
BARRACLOUGH CA, 1982, ENDOCR REV, V3, P91, DOI 10.1210/edrv-3-1-91
[4]   EVIDENCE OF AN INCERTO-HYPOTHALAMIC DOPAMINE NEURON SYSTEM IN RAT [J].
BJORKLUND, A ;
LINDVALL, O ;
NOBIN, A .
BRAIN RESEARCH, 1975, 89 (01) :29-42
[5]   INVIVO OUTPUT OF DOPAMINE AND METABOLITES FROM THE RAT CAUDATE-NUCLEUS AS ESTIMATED WITH PUSH-PULL PERFUSION ONLINE WITH HPLC-EC IN UNRESTRAINED, CONSCIOUS RATS .1. CHROMATOGRAPHIC AND BIOLOGICAL VALIDATION [J].
CHEN, JC ;
RHEE, KK ;
BEAUDRY, DM ;
RAMIREZ, VD .
NEUROENDOCRINOLOGY, 1984, 38 (05) :362-370
[6]   POSITIVE AND NEGATIVE FEEDBACK EFFECTS OF OVARIAN-STEROIDS ON LUTEINIZING-HORMONE RELEASE IN OVARIECTOMIZED RATS FOLLOWING CHRONIC DEPLETION OF HYPOTHALAMIC NOREPINEPHRINE [J].
CLIFTON, DK ;
SAWYER, CH .
ENDOCRINOLOGY, 1980, 106 (04) :1099-1102
[7]  
COM M, 1987, TRENDS NEUROSCI, V10, P473
[8]   REGULATION OF NEUROPEPTIDE GENE-EXPRESSION BY STEROID-HORMONES [J].
HARLAN, RE .
MOLECULAR NEUROBIOLOGY, 1988, 2 (03) :183-200
[9]   CATECHOLAMINE INNERVATION OF HYPOTHALAMUS WITH SPECIAL REFERENCE TO MEDIAN-EMINENCE [J].
JONSSON, G ;
HOKFELT, T ;
FUXE, K .
BRAIN RESEARCH, 1972, 40 (02) :271-&
[10]   NEURAL REGULATION OF LUTEINIZING-HORMONE SECRETION IN THE RAT [J].
KALRA, SP ;
KALRA, PS .
ENDOCRINE REVIEWS, 1983, 4 (04) :311-351